文摘
The nitrogen-containing bisphosphonates (N-BPs) are the main drugs currently used to treat diseases characterized by excessive bone resorption. The major molecular target of N-BPs is farnesylpyrophosphate synthase. N-BPs inhibit the enzyme by a mechanism that involves time dependent isomerization of the enzyme. We investigated features of N-BPs that confer maximal slow and tight-binding by quantifying the initial and final Kis and calculating the isomerization constant Kisom for many N-BPs. Disruption of the phosphonate−carbon−phosphonate backbone resulted in loss of potency and reduced Kisom. The lack of a hydroxyl group on the geminal carbon also reduced Kisom. The position of the nitrogen in the side chain was crucial to both Ki and Kisom. A correlation of Kisom and also final Ki with previously published in vivo potency reveals that the isomerization constant (R = −0.77, p < 0.0001) and the final inhibition of FPPS by N-BPs (R = 0.74, p < 0.0001) are closely linked to antiresorptive efficacy.